Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51


Whole exome sequencing to identify genetic markers for trastuzumab-induced cardiotoxicity.

Udagawa C, Nakamura H, Ohnishi H, Tamura K, Shimoi T, Yoshida M, Yoshida T, Totoki Y, Shibata T, Zembutsu H.

Cancer Sci. 2018 Feb;109(2):446-452. doi: 10.1111/cas.13471. Epub 2018 Jan 24.


Targeted Nanomaterials for Phototherapy.

Chitgupi U, Qin Y, Lovell JF.

Nanotheranostics. 2017 Jan 1;1(1):38-58. doi: 10.7150/ntno.17694. eCollection 2017. Review.


Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis B.

Malecki M, Sabo C, Foorohar A, Tombokan X.

Clin Transl Med. 2016 Dec;5(1):32. doi: 10.1186/s40169-016-0111-8. Epub 2016 Aug 18.


Targeted Reconstitution of Cytokine Activity upon Antigen Binding using Split Cytokine Antibody Fusion Proteins.

Venetz D, Koovely D, Weder B, Neri D.

J Biol Chem. 2016 Aug 26;291(35):18139-47. doi: 10.1074/jbc.M116.737734. Epub 2016 Jul 8.


Therapeutic Considerations in Treating HER2-Positive Metastatic Breast Cancer.

O'Sullivan CC, Smith KL.

Curr Breast Cancer Rep. 2014 Sep 1;6(3):169-182.


HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer.

Green AR, Barros FF, Abdel-Fatah TM, Moseley P, Nolan CC, Durham AC, Rakha EA, Chan S, Ellis IO.

Breast Cancer Res Treat. 2014 May;145(1):33-44. doi: 10.1007/s10549-014-2925-7. Epub 2014 Apr 6.


Effects of hormonotherapy administered after concurrent radiotherapy and Trastuzumab on pulmonary fibrosis.

Benderli Cihan Y, Deniz K, Mutlu H, Kaplan B.

Hippokratia. 2013 Jul;17(3):228-32.


Heparan sulfate mediates trastuzumab effect in breast cancer cells.

Suarez ER, Paredes-Gamero EJ, Del Giglio A, Tersariol IL, Nader HB, Pinhal MA.

BMC Cancer. 2013 Oct 1;13:444. doi: 10.1186/1471-2407-13-444.


From bench to bedside: lessons learned in translating preclinical studies in cancer drug development.

Lieu CH, Tan AC, Leong S, Diamond JR, Eckhardt SG.

J Natl Cancer Inst. 2013 Oct 2;105(19):1441-56. doi: 10.1093/jnci/djt209. Epub 2013 Sep 19. Review.


New developments in the treatment of HER2-positive breast cancer.

Nahta R.

Breast Cancer (Dove Med Press). 2012 May 1;4:53-64.

Supplemental Content

Support Center